chr7-5973396-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_000535.7(PMS2):c.*3G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000087 ( 0 hom., cov: 19)
Exomes 𝑓: 0.000024 ( 2 hom. )
Failed GnomAD Quality Control
Consequence
PMS2
NM_000535.7 3_prime_UTR
NM_000535.7 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.46
Publications
0 publications found
Genes affected
PMS2 (HGNC:9122): (PMS1 homolog 2, mismatch repair system component) The protein encoded by this gene is a key component of the mismatch repair system that functions to correct DNA mismatches and small insertions and deletions that can occur during DNA replication and homologous recombination. This protein forms heterodimers with the gene product of the mutL homolog 1 (MLH1) gene to form the MutL-alpha heterodimer. The MutL-alpha heterodimer possesses an endonucleolytic activity that is activated following recognition of mismatches and insertion/deletion loops by the MutS-alpha and MutS-beta heterodimers, and is necessary for removal of the mismatched DNA. There is a DQHA(X)2E(X)4E motif found at the C-terminus of the protein encoded by this gene that forms part of the active site of the nuclease. Mutations in this gene have been associated with hereditary nonpolyposis colorectal cancer (HNPCC; also known as Lynch syndrome) and Turcot syndrome. [provided by RefSeq, Apr 2016]
PMS2 Gene-Disease associations (from GenCC):
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Lynch syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- mismatch repair cancer syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Muir-Torre syndromeInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 7-5973396-C-T is Benign according to our data. Variant chr7-5973396-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 185828.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,AD gene
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000535.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | NM_000535.7 | MANE Select | c.*3G>A | 3_prime_UTR | Exon 15 of 15 | NP_000526.2 | P54278-1 | ||
| PMS2 | NM_001406866.1 | c.*3G>A | 3_prime_UTR | Exon 16 of 16 | NP_001393795.1 | A0A8V8TNX6 | |||
| PMS2 | NM_001322014.2 | c.*3G>A | 3_prime_UTR | Exon 15 of 15 | NP_001308943.1 | A0A8V8TQ50 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | ENST00000265849.12 | TSL:1 MANE Select | c.*3G>A | 3_prime_UTR | Exon 15 of 15 | ENSP00000265849.7 | P54278-1 | ||
| PMS2 | ENST00000406569.8 | TSL:1 | n.*233G>A | non_coding_transcript_exon | Exon 13 of 13 | ENSP00000514464.1 | P54278-3 | ||
| PMS2 | ENST00000406569.8 | TSL:1 | n.*233G>A | 3_prime_UTR | Exon 13 of 13 | ENSP00000514464.1 | P54278-3 |
Frequencies
GnomAD3 genomes AF: 0.0000867 AC: 10AN: 115298Hom.: 0 Cov.: 19 show subpopulations
GnomAD3 genomes
AF:
AC:
10
AN:
115298
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000151 AC: 3AN: 199080 AF XY: 0.0000277 show subpopulations
GnomAD2 exomes
AF:
AC:
3
AN:
199080
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000244 AC: 20AN: 818390Hom.: 2 Cov.: 11 AF XY: 0.0000211 AC XY: 9AN XY: 425600 show subpopulations
GnomAD4 exome
AF:
AC:
20
AN:
818390
Hom.:
Cov.:
11
AF XY:
AC XY:
9
AN XY:
425600
show subpopulations
African (AFR)
AF:
AC:
0
AN:
20696
American (AMR)
AF:
AC:
0
AN:
35490
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
20372
East Asian (EAS)
AF:
AC:
0
AN:
31246
South Asian (SAS)
AF:
AC:
0
AN:
65762
European-Finnish (FIN)
AF:
AC:
1
AN:
46276
Middle Eastern (MID)
AF:
AC:
0
AN:
2970
European-Non Finnish (NFE)
AF:
AC:
18
AN:
557806
Other (OTH)
AF:
AC:
1
AN:
37772
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000867 AC: 10AN: 115298Hom.: 0 Cov.: 19 AF XY: 0.000109 AC XY: 6AN XY: 54944 show subpopulations
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
10
AN:
115298
Hom.:
Cov.:
19
AF XY:
AC XY:
6
AN XY:
54944
show subpopulations
African (AFR)
AF:
AC:
7
AN:
30412
American (AMR)
AF:
AC:
0
AN:
10874
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2866
East Asian (EAS)
AF:
AC:
0
AN:
3580
South Asian (SAS)
AF:
AC:
0
AN:
3200
European-Finnish (FIN)
AF:
AC:
0
AN:
7630
Middle Eastern (MID)
AF:
AC:
0
AN:
258
European-Non Finnish (NFE)
AF:
AC:
3
AN:
54234
Other (OTH)
AF:
AC:
0
AN:
1478
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.405
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
Pathogenic
VUS
Benign
Condition
-
2
-
Hereditary cancer-predisposing syndrome (2)
-
1
1
not provided (2)
-
1
1
not specified (2)
-
1
-
Hereditary breast ovarian cancer syndrome (1)
-
-
1
Lynch syndrome 4 (1)
-
1
-
PMS2-related disorder (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.